Technologies that induce targeted protein degradation by small molecules have been developed recently. Chimeric small molecules such as Proteolysis Targeting Chimeras (PROTACs) and Specific and Non-genetic IAP-dependent Protein Erasers (SNIPERs), and E3 modulators such as thalidomides, hijack the cellular machinery for ubiquitylation, and the ubiquitylated proteins are subjected to proteasomal degradation. This has motivated drug development in industry and academia because "undruggable targets" can now be degraded by targeted protein degradation.
Keywords: E3 modulator; PROTAC; SNIPER; proteasome; protein degradation; ubiquitin.
Copyright © 2019 Naito, Ohoka, Shibata and Tsukumo.
Selective Degradation of Target Proteins by Chimeric Small-Molecular Drugs, PROTACs and SNIPERs.Pharmaceuticals (Basel). 2020 Apr 21;13(4):E74. doi: 10.3390/ph13040074. Pharmaceuticals (Basel). 2020. PMID: 32326273 Review.
In Vivo Knockdown of Pathogenic Proteins via Specific and Nongenetic Inhibitor of Apoptosis Protein (IAP)-dependent Protein Erasers (SNIPERs).J Biol Chem. 2017 Mar 17;292(11):4556-4570. doi: 10.1074/jbc.M116.768853. Epub 2017 Feb 2. J Biol Chem. 2017. PMID: 28154167 Free PMC article.
SNIPERs-Hijacking IAP activity to induce protein degradation.Drug Discov Today Technol. 2019 Apr;31:35-42. doi: 10.1016/j.ddtec.2018.12.002. Epub 2019 Jan 14. Drug Discov Today Technol. 2019. PMID: 31200857 Review.
Different Degradation Mechanisms of Inhibitor of Apoptosis Proteins (IAPs) by the Specific and Nongenetic IAP-Dependent Protein Eraser (SNIPER).Chem Pharm Bull (Tokyo). 2019 Mar 1;67(3):203-209. doi: 10.1248/cpb.c18-00567. Epub 2018 Oct 26. Chem Pharm Bull (Tokyo). 2019. PMID: 30369550
[Development of Protein Knockdown Technology as Emerging Drug Discovery Strategy].Yakugaku Zasshi. 2018;138(9):1135-1143. doi: 10.1248/yakushi.18-00113. Yakugaku Zasshi. 2018. PMID: 30175757 Review. Japanese.